Variant report
| Variant | nsv962665 |
|---|---|
| Chromosome Location | chr21:15096624-15173241 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:231)
- CpG islands (count:854)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr21:15135580-15135630 | CMK | blood: | n/a |
| 2 | chr21:15135336-15135386 | SK-N-SH | brain: | n/a |
| 3 | chr21:15135043-15135093 | NH-A | brain: | n/a |
| 4 | chr21:15112617-15112667 | HCPEpiC | choroid plexus: | n/a |
| 5 | chr21:15135043-15135093 | HCPEpiC | choroid plexus: | n/a |
| 6 | chr21:15134738-15134788 | GM12892 | blood: | n/a |
| 7 | chr21:15148636-15148686 | SKMC | muscle: | n/a |
| 8 | chr21:15147467-15147517 | HRE | kidney: | n/a |
| 9 | chr21:15135145-15135195 | HCPEpiC | choroid plexus: | n/a |
| 10 | chr21:15096626-15096676 | HRCEpiC | kidney: | n/a |
| 11 | chr21:15138802-15138852 | NH-A | brain: | n/a |
| 12 | chr21:15135580-15135630 | RPTEC | kidney: | n/a |
| 13 | chr21:15144580-15144630 | HepG2 | liver: | n/a |
| 14 | chr21:15112617-15112667 | HRE | kidney: | n/a |
| 15 | chr21:15135043-15135093 | HRE | kidney: | n/a |
| 16 | chr21:15135580-15135630 | NB4 | blood: | n/a |
| 17 | chr21:15134491-15134541 | AG09319 | gingival: | n/a |
| 18 | chr21:15138802-15138852 | SK-N-MC | brain: | n/a |
| 19 | chr21:15135580-15135630 | PANC-1 | pancreas: | n/a |
| 20 | chr21:15135043-15135093 | NHDF-neo | bronchial: | n/a |
| 21 | chr21:15138802-15138852 | PANC-1 | pancreas: | n/a |
| 22 | chr21:15144580-15144630 | HUVEC | blood vessel: | n/a |
| 23 | chr21:15096626-15096676 | ProgFib | skin: | n/a |
| 24 | chr21:15138802-15138852 | U87 | brain: | n/a |
| 25 | chr21:15135580-15135630 | Hela-S3 | cervix: | n/a |
| 26 | chr21:15149415-15149465 | HUVEC | blood vessel: | n/a |
| 27 | chr21:15147467-15147517 | GM12891 | blood: | n/a |
| 28 | chr21:15134491-15134541 | IMR90 | lung: | fetal |
| 29 | chr21:15135336-15135386 | MCF-7 | breast: | n/a |
| 30 | chr21:15134738-15134788 | HCF | heart: | n/a |
| 31 | chr21:15147467-15147517 | HMEC | breast: | n/a |
| 32 | chr21:15134738-15134788 | AG04449 | skin: | fetal |
| 33 | chr21:15135336-15135386 | BJ | skin: | n/a |
| 34 | chr21:15135145-15135195 | Hela-S3 | cervix: | n/a |
| 35 | chr21:15134491-15134541 | HAEpiC | amniotic membrane: | n/a |
| 36 | chr21:15144580-15144630 | NHBE | bronchial: | n/a |
| 37 | chr21:15096626-15096676 | HEEpiC | esophagus: | n/a |
| 38 | chr21:15148636-15148686 | AG10803 | skin: | n/a |
| 39 | chr21:15138802-15138852 | PrEC | prostate: | n/a |
| 40 | chr21:15135336-15135386 | H1-hESC | embryonic stem cell: | embryo |
| 41 | chr21:15112617-15112667 | HepG2 | liver: | n/a |
| 42 | chr21:15134738-15134788 | HRCEpiC | kidney: | n/a |
| 43 | chr21:15112617-15112667 | HEEpiC | esophagus: | n/a |
| 44 | chr21:15096626-15096676 | GM19239 | blood: | n/a |
| 45 | chr21:15131938-15131988 | IMR90 | lung: | fetal |
| 46 | chr21:15135336-15135386 | RPTEC | kidney: | n/a |
| 47 | chr21:15148636-15148686 | SK-N-SH | brain: | n/a |
| 48 | chr21:15134491-15134541 | T-47D | breast: | n/a |
| 49 | chr21:15135336-15135386 | MCF10A-Er-Src | breast: | n/a |
| 50 | chr21:15134738-15134788 | NT2-D1 | testis: | n/a |
| No data |
(count:4 , 50 per page) page:
1
| No. | lncRNA name | Chromosome Location | lncRNA alias |
|---|---|---|---|
| 1 | lnc-LIPI-9 | chr21:15119715-15119817 | l_2168_chr21:15116917-15119815_placenta |
| 2 | lnc-POTED-2 | chr21:15142253-15142534 | XLOC_013860 |
| 3 | lnc-POTED-2 | chr21:15143886-15144061 | XLOC_013860 |
| 4 | lnc-LIPI-9 | chr21:15116918-15118607 | l_2168_chr21:15116917-15119815_placenta |
| No data |
| No data |
| Variant related genes | Relation type |
|---|---|
| FEM1AP1 | TF binding region |
| TERF1P1 | TF binding region |
| ENSG00000224922 | TF binding region |
| FAM207CP | TF binding region |
| FEM1AP1 | CpG island |
| TERF1P1 | CpG island |
| ENSG00000224922 | CpG island |
| FAM207CP | CpG island |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs62214015 | chr21:15096624-15096625 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs143338021 | chr21:15096746-15096747 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs368269327 | chr21:15097890-15097891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs557905034 | chr21:15112025-15112026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs201744304 | chr21:15112113-15112114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs9978792 | chr21:15112246-15112247 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs370248320 | chr21:15112381-15112382 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs200157551 | chr21:15112589-15112590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs375400661 | chr21:15112671-15112672 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs62214059 | chr21:15112828-15112829 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs372362570 | chr21:15112927-15112928 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs7283616 | chr21:15116946-15116947 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 13 | rs368076026 | chr21:15116953-15116954 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 14 | rs200592755 | chr21:15117026-15117027 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 15 | rs201340692 | chr21:15117032-15117033 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 16 | rs112705231 | chr21:15117123-15117124 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 17 | rs372268542 | chr21:15117187-15117188 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 18 | rs374112249 | chr21:15117190-15117191 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 19 | rs149602458 | chr21:15117233-15117234 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 20 | rs536341232 | chr21:15117285-15117286 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 21 | rs111945897 | chr21:15117486-15117487 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 22 | rs62215161 | chr21:15117601-15117602 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 23 | rs112562456 | chr21:15117944-15117945 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 24 | rs61599323 | chr21:15117946-15117947 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 25 | rs374909278 | chr21:15118216-15118217 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 26 | rs61670535 | chr21:15118264-15118265 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 27 | rs372637413 | chr21:15118390-15118391 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 28 | rs377262574 | chr21:15118428-15118429 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 29 | rs200389683 | chr21:15118431-15118432 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 30 | rs374469179 | chr21:15119739-15119740 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
| 31 | rs199680306 | chr21:15130108-15130109 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 32 | rs368983383 | chr21:15130756-15130757 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 33 | rs368881290 | chr21:15130779-15130780 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 34 | rs62215166 | chr21:15132793-15132794 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 35 | rs373881568 | chr21:15132794-15132795 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 36 | rs370455268 | chr21:15133017-15133018 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 37 | rs114401614 | chr21:15134369-15134370 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 38 | rs369455872 | chr21:15134379-15134380 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 39 | rs374158911 | chr21:15134386-15134387 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 40 | rs8130717 | chr21:15134577-15134578 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 41 | rs370156690 | chr21:15134602-15134603 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 42 | rs371785422 | chr21:15134614-15134615 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 43 | rs376850196 | chr21:15134650-15134651 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 44 | rs146554625 | chr21:15137578-15137579 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 45 | rs532601820 | chr21:15138477-15138478 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 46 | rs145562005 | chr21:15138490-15138491 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 47 | rs200709159 | chr21:15144585-15144586 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
| 48 | rs201713340 | chr21:15145427-15145428 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 49 | rs374978950 | chr21:15145484-15145485 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| 50 | rs371531204 | chr21:15145505-15145506 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Ovarian cancer | 21720365 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Esophageal cancer | 21851588 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Cancer | 16751803 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
| Down syndrome | 17412756 | CNVD |
| Down syndrome | 17576883 | CNVD |
| Acute promyelocytic leukemia | 19109227 | CNVD |
| T-cell prolymphocytic leukemia | 17713554 | CNVD |
| Autism | 22495311 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Acute lymphoblastic leukemia | 17690704 | CNVD |
| Sudden cardiac death | 19188705 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Breast cancer | 21509527 | CNVD |
| T-cell lymphomas | 19863542 | CNVD |
| Non-small cell lung cancer | 21044232 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| Seminomas | 18059402 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Congenital abnormalities | 21549014 | CNVD |
| Developmental delay | 21549014 | CNVD |
| Mental retardation | 21549014 | CNVD |
| Acute lymphoblastic leukemia | 21980252 | CNVD |
| Metanephric adenoma | 20802469 | CNVD |
| Neuroblastoma | 18923191 | CNVD |
| Prostate cancer | 19156837 | CNVD |
| Basal cell lymphoma | 17170743 | CNVD |
| Follicular lymphoma | 17170743 | CNVD |
| Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
| Cancer | 20164919 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Acute lymphoblastic leukemia | 21339820 | CNVD |
| Breast cancer | 20409316 | CNVD |
| Autism | 18414403 | CNVD |
| Basal cell lymphoma | 16317097 | CNVD |
| Diffuse large b-cell lymphoma | 16317097 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Hodgkin''s lymphoma | 18641027 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| abnormal development | 18461090 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Breast cancer | 21364760 | CNVD |
| Melanoma | 17363583 | CNVD |
| Breast cancer | 22522925 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr21:15095400-15096800 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
| 2 | chr21:15095800-15096800 | Active TSS | HUES6 Cell Line | embryonic stem cell |
| 3 | chr21:15096600-15096800 | Flanking Active TSS | K562 | blood |
| 4 | chr21:15097800-15098000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
| 5 | chr21:15112000-15112200 | Enhancers | Dnd41 | blood |
| 6 | chr21:15112200-15112400 | Flanking Active TSS | Dnd41 | blood |
| 7 | chr21:15112400-15112600 | Enhancers | Dnd41 | blood |
| 8 | chr21:15112600-15112800 | Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
| 9 | chr21:15112600-15113000 | Flanking Active TSS | Dnd41 | blood |
| 10 | chr21:15112800-15113000 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
| 11 | chr21:15113000-15113200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
| 12 | chr21:15113000-15113200 | Enhancers | Dnd41 | blood |
| 13 | chr21:15147000-15148800 | Enhancers | Dnd41 | blood |
| 14 | chr21:15164800-15165400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
| 15 | chr21:15165400-15165800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
| 16 | chr21:15165400-15167200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
| 17 | chr21:15165600-15167400 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
| 18 | chr21:15165800-15167400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
| 19 | chr21:15166200-15167200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
| 20 | chr21:15167400-15169600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
| 21 | chr21:15169200-15170800 | Enhancers | Dnd41 | blood |
| 22 | chr21:15169600-15171000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
| 23 | chr21:15170000-15170800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |






